Cargando…
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
TRKA expression was evaluated on 122 untreated neuroblastomas by immunohistochemistry using an antibody with predetermined specificity. This procedure is simple and reliable for protein detection at cellular level in a routine clinical setting. Fourteen tumours were classified as benign ganglioneuro...
Autores principales: | Combaret, V., Gross, N., Lasset, C., Balmas, K., Bouvier, R., Frappaz, D., Beretta-Brognara, C., Philip, T., Favrot, M. C., Coll, J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2222795/ https://www.ncbi.nlm.nih.gov/pubmed/9099963 |
Ejemplares similares
-
Expression of P-glycoprotein restricted to normal cells in neuroblastoma biopsies.
por: Favrot, M., et al.
Publicado: (1991) -
Is neuroblastoma screening evaluation needed and feasible?
por: Estève, J., et al.
Publicado: (1995) -
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
por: Favrot, M. C., et al.
Publicado: (1986) -
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells
por: Ruggeri, P, et al.
Publicado: (2016) -
High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)